These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 7738186

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening.
    Wu L, Smythe AM, Stinson SF, Mullendore LA, Monks A, Scudiero DA, Paull KD, Koutsoukos AD, Rubinstein LV, Boyd MR.
    Cancer Res; 1992 Jun 01; 52(11):3029-34. PubMed ID: 1350507
    [Abstract] [Full Text] [Related]

  • 7. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution.
    Baldini N, Scotlandi K, Serra M, Shikita T, Zini N, Ognibene A, Santi S, Ferracini R, Maraldi NM.
    Eur J Cell Biol; 1995 Nov 01; 68(3):226-39. PubMed ID: 8603675
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Relationship of multidrug resistance to rhodamine-123 selectivity between carcinoma and normal epithelial cells: taxol and vinblastine modulate drug efflux.
    Brouty-Boyé D, Kolonias D, Wu CJ, Savaraj N, Lampidis TJ.
    Cancer Res; 1995 Apr 15; 55(8):1633-8. PubMed ID: 7712466
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Identification of non-cross-resistant platinum compounds with novel cytotoxicity profiles using the NCI anticancer drug screen and clustered image map visualizations.
    Fojo T, Farrell N, Ortuzar W, Tanimura H, Weinstein J, Myers TG.
    Crit Rev Oncol Hematol; 2005 Jan 15; 53(1):25-34. PubMed ID: 15607933
    [Abstract] [Full Text] [Related]

  • 13. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.
    Life Sci; 2008 Nov 21; 83(21-22):700-8. PubMed ID: 18845169
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vitro evaluation of new anticancer drugs, exemplified by vinorelbine, using the fluorometric microculture cytotoxicity assay on human tumor cell lines and patient biopsy cells.
    Fridborg H, Nygren P, Dhar S, Csoka K, Kristensen J, Larsson R.
    J Exp Ther Oncol; 1996 Sep 21; 1(5):286-95. PubMed ID: 9414416
    [Abstract] [Full Text] [Related]

  • 16. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells.
    Zhang T, Guan M, Jin HY, Lu Y.
    Gynecol Oncol; 2005 May 21; 97(2):501-7. PubMed ID: 15863151
    [Abstract] [Full Text] [Related]

  • 17. Medroxyprogesterone-acetate reverses the MDR phenotype of the CG5-doxorubicin resistant human breast cancer cell line.
    Zibera C, Gibelli N, Maestri L, Della Cuna GR.
    Anticancer Res; 1995 May 21; 15(3):745-9. PubMed ID: 7645952
    [Abstract] [Full Text] [Related]

  • 18. Development of doxorubicin resistant rat prostate cancer cell lines.
    Replogle-Schwab TS, Schwab ED, Pienta KJ.
    Anticancer Res; 1997 May 21; 17(6D):4535-8. PubMed ID: 9494564
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of JNK/SAPK activity is associated with the cross-resistance to P-glycoprotein-unrelated drugs in multidrug-resistant FM3A/M cells overexpressing P-glycoprotein.
    Kang CD, Ahn BK, Jeong CS, Kim KW, Lee HJ, Yoo SD, Chung BS, Kim SH.
    Exp Cell Res; 2000 Apr 10; 256(1):300-7. PubMed ID: 10739677
    [Abstract] [Full Text] [Related]

  • 20. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS, Hua J, Gibb RK, Mutch DG, Herzog TJ.
    Gynecol Oncol; 2004 Jul 10; 94(1):67-73. PubMed ID: 15262121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.